The importance of oncogenes in the development of human cancer has been amply demonstrated in recent years by the ability of these genes to cause tumorigenic conversion of rodent cells. There can be no doubt that other human genes exist which are not classified as oncogenes per se but which play important roles in the development and progression of cancer. One category of these genes encodes abundant structural proteins such as the actins and tropomyosins. The involvement of these abundant proteins in the neoplastic transformation process is suggested by the well-documented observations that isoforms within these structural protein families are consistently modulated in the transformation of avian (16, 38) , rodent (6, 9, 19, 28) , and human (19, 21, 23, 24) cells. This second category of cancer-related genes is set apart from the so-called oncogenes because modulation of these genes in a transformation-sensitive manner is likely to result from regulatory processes activating transcription or translation rather than from direct activation through mutational processes (5, 36) .
Previously, we examined the abundant proteins synthesized in normal and transformed human fibroblasts by means of comparative high-resolution two-dimensional (2-D) polyacrylamide gel electrophoresis and identified an abundant phosphorylated polypeptide, plastin (p219/p220 [20] ; Mr, 68,000; pl 5.3) , that is frequently expressed in human cancer cells of solid tissue but that is not expressed in normal human fibroblasts (13, 14, 20, 22, 23) . When we examined proteins of normal peripheral blood leukocytes, we found that the same protein was one of the most abundant constitutively expressed proteins of leukocytes (13) . Cross identification of plastin in the transformed fibroblasts and leukocytes was based upon the finding that the protein identified as plastin in mixed proteins of the two cell types comigrated in a 2-D gel as a single spot. Furthermore, two separate peptide antibodies specific for the amino acid sequence around residue 244 of actin cross-reacted with plastin from either transformed fibroblasts or lymphocytes in a 2-D gel Western blot (immunoblot) (37) . Goldman and colleagues (12, 20) observed that plastin (p301 [12] or p219/p220 [20] ) was polymorphic in charge among 28 individuals whose leukocyte proteins were examined by 2-D gel electrophoresis. They later referred to this protein as NIMH4 and NC4 (10, 11) . Together we determined that NIMH4 (or NC4) and I-plastin of fibroblasts were the same polypeptide (20) . Later, Goldstein et al. also reported that I-plastin was polymorphic in human leukocytes (13) . Independently, Kondo and Hamaguchi (18) used the polymorphic character of plastin (LCP1, NIMH4, NC4, or p219/p220) in a gene segregation analysis to link the I-plastin gene to the esterase D and retinoblastoma loci on human chromosome 13. This linkage of the plastin gene to the esterase D gene has been supported in a separate gene segregation study by Goldman (David Goldman, National Institute of Alcohol and Drug Abuse, Bethesda, Md., personal communication). Despite the reproducible identification of plastin and these studies of its expression and polymorphic character, nothing was known of its molecular identity.
To study the cellular function of plastin and the mechanisms controlling plastin gene expression, we attempted to clone the cDNA of the plastin mRNA. By the use of a degenerate oligonucleotide probe derived from an internal protein sequence of plastin directly isolated from analytical 2-D electrophoretic gels, we have identified two different, but highly related, cDNA clones of plastin mRNA. Our main conclusions are the following: (1) there exist at least two isoforms of plastin, I-plastin and t-plastin; (ii) the expression of I-plastin and t-plastin is regulated in a tissue-specific manner; and (iii) I-plastin is a marker protein for transformed cells of fibroblasts and some cells of epithelial or endothelial origin.
MATERIALS AND METHODS
Methods for growing cells for the preparation of cellular RNA, genomic DNA, and protein extracts and the proce- dure for 2-D gel electrophoresis have been described in detail previously (22, 23, 25) . Silver staining of proteins in a gel was done by the procedure of Merril et al. (30) .
Protein sequencing. Protein sequencing methods have been described previously (1) (2) (3) 17) . In brief, cellular proteins were separated by 2-D gel electrophoresis and transferred to nitrocellulose paper, each protein spot of interest was cut out and digested by trypsin, and the resulting peptides were separated by narrow-bore, reverse-phase high-pressure liquid chromatography and sequenced in a gas phase sequenator.
Screening of cDNA library. A AgtlO cDNA library constructed from HuT-14 poly(A)+ RNA has been described previously (25) (26, 27) . Approximately 10 ,ug of each DNA was digested with Hindlll to completion, electrophoresed on a 0.7% agarose gel, and transferred to nitrocellulose paper by the method described by Southern (35) . Hybridization and washing of the nitrocellulose paper were the same as described above.
DNA sequencing. DNA was cloned into M13mp9 (31) . Progressive deletion clones were prepared by the method described by Dale et al. (7) and sequenced by the method described by Sanger et al. (34) . Sequence information was managed by Bionet of Intelligenetics Inc., Palo Alto, Calif.
In vitro message selection-translation. To confirm the identity of a cDNA, in vitro message selection-translation was used. We have described this methodology in detail previously (25) . In brief, cDNA was bound to nitrocellulose paper and hybridized with poly(A)+ RNA, hybridized RNA was recovered and translated in a rabbit reticulocyte system, and the translational product was separated by 2-D gel electrophoresis and visualized by autoradiography.
RESULTS
Evidence for two isoforms. We initially attempted a differential hybridization approach, using two probes derived from mRNAs of diploid ("plastin-negative") KD fibroblast cells and transformed ("plastin-positive") HuT (2) . The resulting peptides were separated by narrow-bore, reverse-phase high-pressure liquid chromatography, and individual peptide fragments were sequenced in a modified Caltech gas phase sequenator (17) . Four peptide sequences that were unambiguously identified are listed in Table 1 , footnote a.
We synthesized a degenerate oligonucleotide 20-mer corresponding to one of the four oligopeptides (Table 1) and used it to screen a XgtlO cDNA library of transformed (HuT-14) human fibroblasts (25) . From (senseque) b An eightfold degenerate 20-nucleotide probe was designed from the I-plastin peptide 3 sequence that exhibited a relatively low degeneracy. This oligonucleotide was synthesized by using an ABI solid-phase synthesizer. We preferred to use a relatively short oligonucleotide probe with low degeneracy. To further minimize degeneracy, we made use of preferred codon usage for valine and the weak base pair-stabilizing characteristics of inosine (I) in the isoleucine codon (32).
3' End, .... blasts ( Fig. 3B and C ), but were undetectable in leukocytes ( Fig. 3A and E) . As these two proteins were apparently similar to plastin, we decided to use the 2-kb Hindlll fragment of P4 cDNA as a probe to rescreen the HuT-14 cDNA library in the hope of finding related cDNAs.
Several clones were identified by this rescreening. One of them, P107, had the largest insert cDNA (3.7 kb) and was chosen for further examination. In Northern analysis (Fig.  1B) , P107 hybridized to an mRNA of 3.7 kb that was more abundant in CEM lymphocytes (lane 1), less abundant in transformed HuT-14 fibroblasts (lane 3) , and not detectable in untransformed KD fibroblasts (lane 2). This was the predicted pattern for I-plastin mRNA expression in these three cell types (13) . Translation of HuT-14 mRNAs selected by this clone yielded a single polypeptide species that appeared to be identical to I-plastin in a 2-D gel (Fig. 3H) . We established that this in vitro-synthesized polypeptide was electrophoretically identical to I-plastin by mixing the in vitro translation sample in Fig. 3H with labeled unfractionated HuT-12 cellular proteins (23) shown in Fig. 3J . The in vitro-translated I-plastin, which was in excess of the endogenous HuT-12 I-plastin, was superimposed upon the endogenous I-plastin after 2-D gel electrophoresis (Fig. 3K) . We therefore concluded that P107 is the true cDNA clone of I-plastin, whereas P4 cDNA encoded separate polypeptide isoforms, t-plastins, which closely related to I-plastin.
DNA sequencing of P107 cDNA revealed a coding sequence closely related to that of the initially characterized P4 clone (Fig. 2) . The P107 cDNA sequence contained the amino acid residues determined by protein sequence analysis of plastin isolated from CEM lymphocytes in the positions where discrepancies had existed between the protein sequence and the P4 cDNA sequence. Each coding sequence encoded a polypeptide of 570 amino acids with molecular weight of 64,000. This value is slightly different from our observed Mr value of I-plastin and the two t-plastin polypeptides (Mr-68,000) in a 2-D gel (13, 23) , but is consistent with the value for I-plastin observed by others (18, 29) . Our predicted amino acid composition obtained for plastin by computerized microdensitometry was consistent with the amino acid composition determined from these DNA sequences (13) .
The existence of two closely related plastin isoforms, I-plastin of leukocytes and the t-plastins of normal fibroblasts, explains why we were unable to identify plastin cDNA clones through differential hybridization, for the plastin-negative fibroblast probe contained t-plastin sequences that would hybridize to any I-plastin clones. That I-plastin is expressed in leukocytes and in transformed fibroblasts (HuT-14) but not in normal fibroblasts is confirmed because the oligopeptide sequences were derived from I-plastin of lymphocytes and the I-plastin cDNA clone was isolated from transformed fibroblasts. The t-plastin isoforms, on the other hand, are expressed in both normal and transformed fibroblasts, but not in leukocytes.
Differential expression of plastin isoforms in human cell transformation. We surveyed a panel of cultured human cell 4661 VOL. 8, 1988 M strains by Northern analysis for I-plastin (Fig. 4A) and more than 50 additional diploid human fibroblast strains t-plastin (Fig. 4B) mRNA. I-Plastin mRNA and protein were derived from embryonic lung, skin, foreskin, and gingiva not detected in the diploid human fibroblast strains KD and from normal individuals and from patients with various R17 (Fig. 4A, lanes 1 and 2; example shown in Fig. 3B ), but genetic diseases such as Huntington's disease, Bloom's both strains exhibited t-plastin mRNA (Fig. 4B, lanes 1 and syndrome, ataxia telangiectasia, and retinoblastoma. With-2) and protein (example shown in Fig. 3B ). We examined out exception all diploid fibroblast strains exhibited expres-MOL. CELL. BIOL.
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sion of t-plastin in 2-D protein profiles, but not I-plastin. The with 2-D protein gel analysis for these two cell lines (23) . The two transformed fibroblast strains,  tumorigenic strain HuT-14 expressed more I-plastin mRNA derived after mutagenesis of the KD cell culture (23), exhiband protein than did the three nontumorigenic HuT strains ited increasing levels of I-plastin mRNAs (Fig. 4, lanes 3 and (HuT-11, -12, and -13) ( Fig. 3C and D; Fig. 4A , lanes 3 and 4, respectively), consistent with our previous observations 4; references 20 and 23) . HuT-14T, an even more tumorige-
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nic substrain of (19, 23) , was not elevated further in HOS synthesizes a low level of 1-plastin which is barely I-plastin expression (Fig. 4A, lane 5 ; reference 23). The detectable in 2-D gels (14) , but I-plastin mRNA could not be human fibrosarcoma cell line (HT1080) and leiomyosarcoma detected in HOS cells by Northern blot analysis (Fig. 4A , cell line (Sarcoma-2) also expressed I-plastin mRNAs at lane 8). A second osteogenic sarcoma, MG63, and a retinolevels comparable to those of the HuT strains (Fig. 4A , lanes blastoma tumor cell line, GM1231A, did not exhibit either 6 and 7, respectively). These two cell lines were previously the I-plastin mRNA transcript (Fig. 4A, lanes 13 and 11, shown to express levels of I-plastin protein comparable to respectively) or the I-plastin polypeptide (data not shown). that of the HuT strains (14) . The osteogenic sarcoma cell line (Fig. 4A, lanes 9, 10, and 12, respectively), but no detectable t-plastin mRNA (Fig. 4B, lanes 9, 10, and 12, respectively) . Leukemic cell lines such as CEM (Fig. 3A) and normal leukocytes such as peripheral blood leukocytes (13) and cultured monocytes (Fig. 3E) synthesize the highest levels of I-plastin protein (13) , but no t-plastin protein ( Fig. 3A and E (6, 21, 36) , and found that both synthesize plastins and mRNA corresponding to the human t-plastin isoform (Fig. 4A, lanes 14 and 15; (21) . We have concluded that whereas t-plastin isoform is well conserved between humans and rodents, the polypeptide of I-plastin isoform of rodents is too divergent from that of humans to be recognized by 2-D gel analysis and that, unlike human I-plastin, the rodent I-plastin does not appear to be transformation inducible in fibroblasts.
Plastin genomic sequences. We investigated the genomic representation of both the 1-and the t-plastin isoforms in six cell strains. The results (Fig. 5) indicate that the 1-and t-plastin genes are located on separate DNA restriction fragments in the human genome, and there is no detectable difference in the restriction digest pattern of the t-plastin gene among all six human cell strains examined (Fig. 5A ). There is also no detectable difference in the restriction digest pattern of the I-plastin gene between diploid human fibroblasts which do not synthesize I-plastin and transformed HuT-12 and HuT-14 human fibroblast strains which synthesize increasing levels of the I-plastin. The genomic DNA of peripheral blood leukocytes derived from a healthy human donor has two Hindlll fragments of 6.5 and 6.0 kb (Fig. SB,  lane 4) instead of the single band of 6.5 kb found in the other five genomic DNA samples. The peripheral blood leukocytes of this individual synthesized the variant (polymorphic) form of the I-plastin (13) in addition to the normal-charge species of I-plastin. The 6.0-kb fragment, therefore, may be indicative of this variant form of I-plastin. The B-lymphoblast AG1484 (Fig. SB, lane 5 ) and the retinoblastoma cell strain GM1231A (Fig. SB, lane 6) The divergence of 1-and t-plastin is striking because these two proteins, though they are clearly related, have diverged by 17% of their amino acids, with these replacements scattered almost randomly throughout the 570 amino acid residues of the plastin sequence. Thirty-three percent of these amino acid exchanges involve charged amino acid replacements, with seven We scanned three protein sequence data bases (EMBL, National Institutes of Health, and another one compiled by Russell Doolittle, University of California, San Diego) for sequences that were related to plastin and found that no related protein or peptide sequence has yet been cataloged. Recently, Matsushima et al. (29) reported the purification and characterization of a cytosolic 65-kilodalton phosphoprotein in human leukocytes. This protein is clearly I-plastin because a sequence of 22 amino acids (29) is identical to the amino acid sequence of I-plastin between residues 533 and 554 (Fig. 2) . Their characterization of this protein as a highly abundant, N-blocked phosphoprotein of all major leukocyte subpopulations which is not expressed in normal human fibroblasts or HeLa cells is consistent with our findings presented here and in other publications (13, 18) . Furthermore, their finding that I-plastin is phosphorylated at sefine residues is consistent with the results of Anderson et al. (4 
